TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15791626

Group type: EXPERIMENTAL
Intervention: Duration of labor screening test model
Number of subjects: 691

Group type: COMPARATOR
Intervention: Duration of labor cutoff value
Number of subjects: 691
Study: 14703408

Group type: EXPERIMENTAL
Intervention: Gene therapy + radiotherapy (GTRT group, n = 20) - SBN‐1 solution 1 x 10(12) VP injected intratumorally once a week for 8 weeks, radiotherapy started on the 3rd day of gene therapy, 5 fractions a week with a fraction dosage of 2 Gy and total dosage of 70 Gy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Radiotherapy (RT group, n = 22) - the above regimen of radiotherapy conducted
Number of subjects: 42
Study: 10459960

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 1670

Group type: COMPARATOR
Intervention: Control group (no antihypertensive treatment)
Number of subjects: 1670
Study: 8736647

Group type: EXPERIMENTAL
Intervention: 30 mM glucose perfusate
Number of subjects: 0
Study: 1679154

Group type: EXPERIMENTAL
Intervention: Heparin treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heparin treatment after intracranial hemorrhage (ICH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No heparin treatment after ICH
Number of subjects: 20
Study: 6385766

Group type: EXPERIMENTAL
Intervention: nalbuphine 20 mg i.m.
Number of subjects: 49

Group type: COMPARATOR
Intervention: morphine 10 mg i.m.
Number of subjects: 49
Study: 31632686

Group type: EXPERIMENTAL
Intervention: Single antibiotic (cefprozil)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cocktail of three antibiotics (meropenem, gentamicin, and vancomycin)
Number of subjects: 30
Study: 29269138

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age-related decline
Number of subjects: 0
Study: 27565435

Group type: EXPERIMENTAL
Intervention: IIV4 (quadrivalent influenza vaccine)
Number of subjects: 1242

Group type: COMPARATOR
Intervention: IIV3 (trivalent comparator)
Number of subjects: 1242

Group type: COMPARATOR
Intervention: IIV3 (licensed Northern Hemisphere IIV3)
Number of subjects: 1242
Study: 25224876

Group type: EXPERIMENTAL
Intervention: GIC‐1001 (trimebutine 3‐thiocarbamoylbenzenesulfonate)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GIC‐1001 (single-dose administration)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GIC‐1001 (food effect)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GIC‐1001 (multiple ascending doses)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 19445342

Group type: EXPERIMENTAL
Intervention: Forgiveness therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 20
Study: 15200937

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11902593

Group type: EXPERIMENTAL
Intervention: IV cyclophosphamide and prednisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly plasma exchange, oral cyclophosphamide, and prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham plasma exchange and placebo medications
Number of subjects: 0
Study: 9295106

Group type: EXPERIMENTAL
Intervention: ACTH 4-10 (2 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7956624

Group type: EXPERIMENTAL
Intervention: Diabetic patients (n=12)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy control subjects (n=17)
Number of subjects: 29
Study: 2885987

Group type: EXPERIMENTAL
Intervention: salazosulfapyridine
Number of subjects: 81

Group type: COMPARATOR
Intervention: aurothioglucose
Number of subjects: 81
Study: 31051506

Group type: EXPERIMENTAL
Intervention: Sodium reduction (SR)
Number of subjects: 133
Study: 30247596

Group type: EXPERIMENTAL
Intervention: Recombinant adjuvanted zoster vaccine (HZ/su), administered in 2 doses separated by 60 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Live attenuated zoster vaccine (ZV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant adjuvanted zoster vaccine (HZ/su)
Number of subjects: 0
Study: 29328644

Group type: EXPERIMENTAL
Intervention: Triple eradication therapy with probiotics (Lactobacillus Rosell‐52, Lactobacillus Rosell‐11, Bifidobacterium Rosell‐1755, Saccharomyces boulardii)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Triple eradication therapy without probiotics
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Triple eradication therapy with probiotics
Number of subjects: 167
Study: 24788114

Group type: EXPERIMENTAL
Intervention: Child Development Accounts (CDAs) offered to treatment participants, based on the Oklahoma 529 College Savings Plan
Number of subjects: 2704
Study: 23158465

Group type: EXPERIMENTAL
Intervention: Chiropractic manual therapy (individualized treatment of the spine)
Number of subjects: 104
Study: 21456104

Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB) 300-600 mg/day
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Venlafaxine-XR (VXR) 75-225 mg/day
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Venlafaxine-XR (VXR)
Number of subjects: 121
Study: 17998547

Group type: EXPERIMENTAL
Intervention: Nutrition intervention
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 252
Study: 15310736

Group type: EXPERIMENTAL
Intervention: Milk (MILK)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Carbohydrate-electrolyte (CHO)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both MILK and CHO
Number of subjects: 19
Study: 11879296

Group type: EXPERIMENTAL
Intervention: Home-based moderate walking exercise intervention (at least 90 minutes per week on 3 or more days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 9747065

Group type: EXPERIMENTAL
Intervention: 30-mg transdermal nicotine patch
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 62
Study: 8155071

Group type: EXPERIMENTAL
Intervention: Active Low Energy Emission Therapy (LEET)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Inactive Low Energy Emission Therapy (LEET)
Number of subjects: 52
Study: 2845031

Group type: EXPERIMENTAL
Intervention: CVIS instructional program on therapeutic communication
Number of subjects: 75

Group type: COMPARATOR
Intervention: Lecture discussion on therapeutic communication and a videotape (Control)
Number of subjects: 75
Study: 31369676

Group type: EXPERIMENTAL
Intervention: Quad-helix treatments in specialist orthodontic clinics (QHS)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Quad-helix treatments in general dentistry (QHG)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Removable expansion plate treatments in specialist orthodontic clinics (EPS)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Removable expansion plate treatments in general dentistry (EPG)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Untreated crossbite (UC)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Normal occlusion (control group)
Number of subjects: 135
Study: 29567359

Group type: EXPERIMENTAL
Intervention: Urticaria Activity and Impact Measure (U‐AIM)
Number of subjects: 206
Study: 27650732

Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26386791

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 5695

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 5695
Study: 23403597

Group type: EXPERIMENTAL
Intervention: Dance intervention (dance classes twice weekly for 8 months, 75 minutes each class)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dance intervention
Number of subjects: 112
Study: 21371172

Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal™
Number of subjects: 27

Group type: COMPARATOR
Intervention: LMA‐Classic™
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal™ (suboptimal position)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal™ (optimal position)
Number of subjects: 27
Study: 18555581

Group type: EXPERIMENTAL
Intervention: Glucose laden drink
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 0
Study: 17042850

Group type: EXPERIMENTAL
Intervention: Forced-air warming (Bair Hugger, Augustine Medical model 500/OR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electric heating pad (Operatherm 202, KanMed)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Forced-air warming and Electric heating pad
Number of subjects: 60
Study: 12972528

Group type: EXPERIMENTAL
Intervention: Combined-modality treatment (CMT)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Subtotal lymphoid irradiation (STLI)
Number of subjects: 247
Study: 10730734

Group type: EXPERIMENTAL
Intervention: Ephedrine (5 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dobutamine (3 microg x kg(‐1) x min(‐1))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dopamine (5 microg x kg(‐1) x min(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no vasopressor)
Number of subjects: 40
Study: 9197908

Group type: EXPERIMENTAL
Intervention: High levels of artificial light (phototherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low levels of artificial light (phototherapy)
Number of subjects: 0
Study: 1443487

Group type: EXPERIMENTAL
Intervention: Inhalational anaesthetic
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total intravenous anaesthetic
Number of subjects: 40
Study: 3455945

Group type: EXPERIMENTAL
Intervention: Electric toothbrush (Rota‐dent) with instruction by a dental hygienist
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral hygiene kit with conventional toothbrush and self-teaching manual
Number of subjects: 40
Study: 30981288

Group type: EXPERIMENTAL
Intervention: Backboard present
Number of subjects: 101

Group type: COMPARATOR
Intervention: No backboard
Number of subjects: 101
Study: 29289901

Group type: EXPERIMENTAL
Intervention: CLL/SLL cases with first degree relatives with hematological cancer
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: CLL/SLL cases who have ever worked in agriculture
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Women with CLL/SLL and central obesity
Number of subjects: 560

Group type: COMPARATOR
Intervention: Current alcohol consumption
Number of subjects: 560

Group type: COMPARATOR
Intervention: Type II diabetes
Number of subjects: 560
Study: 26914594

Group type: EXPERIMENTAL
Intervention: 4-week PRT
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 2-week PRT
Number of subjects: 57
Study: 25125505

Group type: EXPERIMENTAL
Intervention: Pistachio-supplemented diet (PD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control diet (CD)
Number of subjects: 54
Study: 22913248

Group type: EXPERIMENTAL
Intervention: Chicken meat from chickens given a feed with 2% rapeseed oil plus 2% linseed oil (RLO)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Chicken meat from chickens given a feed concentrate containing 4% soybean oil (SO)
Number of subjects: 46
Study: 20473045

Group type: EXPERIMENTAL
Intervention: Intra-articular corticosteroid injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pulsed radiofrequency (PRF) to the suprascapular nerve
Number of subjects: 50
Study: 17850530

Group type: EXPERIMENTAL
Intervention: 38-item paper and pencil survey assessing workforce perceptions of hospital safety culture
Number of subjects: 21496
Study: 16140428

Group type: EXPERIMENTAL
Intervention: L-arginine (10 g daily for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vitamin C (500 mg daily for 4 weeks)
Number of subjects: 31
Study: 11947910

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg once daily for 8 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10447905

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epidural hydromorphone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl
Number of subjects: 90
Study: 8563153

Group type: EXPERIMENTAL
Intervention: Intensive 3 1/2-week pain rehabilitation program
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (age- and gender-matched)
Number of subjects: 57
Study: 2138493

Group type: EXPERIMENTAL
Intervention: Minocycline (50 mg b.d.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tetracycline (500 mg b.d.)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 25
Study: 27397

Group type: EXPERIMENTAL
Intervention: 0.1% dimetindene maleate gel
Number of subjects: 11

Group type: COMPARATOR
Intervention: 1% d‐chlorpheniramine maleate cream
Number of subjects: 11
Study: 31756632

Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 30831331

Group type: EXPERIMENTAL
Intervention: Mobile health (mHealth) technologies (eg, apps, wearables)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 27718765

Group type: EXPERIMENTAL
Intervention: Vaginal ALA 400 mg daily for 30 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26390908

Group type: EXPERIMENTAL
Intervention: Duette multifocal (SynergEyes)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Air Optix AQUA multifocal (Alcon)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Biofinity multifocal (CooperVision)
Number of subjects: 8
Study: 23943184

Group type: EXPERIMENTAL
Intervention: Voriconazole prophylaxis
Number of subjects: 599

Group type: COMPARATOR
Intervention: Fluconazole prophylaxis
Number of subjects: 599
Study: 20833455

Group type: EXPERIMENTAL
Intervention: Integrated pharmacology and medicines management curriculum
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual curriculum (control group)
Number of subjects: 120
Study: 19214921

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 0
Study: 16886113

Group type: COMPARATOR
Intervention: Systemic chemotherapy (5‐fluorouracil, pirarubicin, mitomycin) for two courses
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Arterial infusion chemotherapy (5‐fluorouracil, pirarubicin, mitomycin) for four courses
Number of subjects: 368
Study: 15800329

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ) 75 mg/m²/d orally concomitantly with RT (60 Gy in 30 fractions) followed by six cycles of TMZ (150 mg/m² on days 1-5 and 15-19 every 28 days)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone (60 Gy in 30 fractions)
Number of subjects: 130
Study: 11303488

Group type: EXPERIMENTAL
Intervention: Weekly iron (120 mg Fe as FeSO4) and folic acid (500 microg)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Weekly iron (120 mg Fe as FeSO4) and folic acid (500 microg) plus vitamin A (4800 RE)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Daily iron and folic acid (national program)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 366
Study: 9470402

Group type: EXPERIMENTAL
Intervention: Electrical stimulation-induced knee flexion/extension (ES)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Voluntary knee flexion/extension (VOL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Passive knee flexion/extension (PAS)
Number of subjects: 16
Study: 8336988

Group type: EXPERIMENTAL
Intervention: Cued for mood experience
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Cued for pain experience
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Recognition of chosen words
Number of subjects: 49

Group type: COMPARATOR
Intervention: General anaesthetic
Number of subjects: 49
Study: 3720176

Group type: EXPERIMENTAL
Intervention: Intravenous nifedipine (4.5 mg in 45 minutes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral nifedipine (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control subjects (not specified dosage)
Number of subjects: 0
Study: 2742440

Group type: EXPERIMENTAL
Intervention: Usual physician advice + 2 counseling sessions with a smoking cessation counselor
Number of subjects: 155

Group type: COMPARATOR
Intervention: Usual physician advice
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Higher motivation smokers in intervention group
Number of subjects: 155

Group type: COMPARATOR
Intervention: Higher motivation smokers in control group
Number of subjects: 155
Study: 30970152

Group type: EXPERIMENTAL
Intervention: Targeted behavioural based intervention (asynchronous e-learning module)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Knowledge based active control (asynchronous e-learning module)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: All participants (regardless of study arm)
Number of subjects: 420
Study: 28631582

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) 500 mg/d for 8 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE)
Number of subjects: 8
Study: 26156280

Group type: EXPERIMENTAL
Intervention: N2O-O2 sedation
Number of subjects: 40

Group type: COMPARATOR
Intervention: O2 (control)
Number of subjects: 40
Study: 23515614

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Low cyclin D1 expression
Number of subjects: 232

Group type: COMPARATOR
Intervention: High cyclin D1 expression
Number of subjects: 232
Study: 21740089

Group type: EXPERIMENTAL
Intervention: Infrared-LED (850 nm) plus treadmill training (45 minutes twice a week for 3 months at 85%-90% HR(max), 39 mW/cm(2), fluence of 106 J/cm(2))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treadmill training only (control group)
Number of subjects: 20
Study: 19908337

Group type: EXPERIMENTAL
Intervention: Fructose-sorbitol (F-S) ingestion (25 g fructose/5 g sorbitol)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Glucose ingestion (50 g glucose)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fructose-sorbitol (F-S) ingestion
Number of subjects: 26
Study: 16289976

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once daily
Number of subjects: 30
Study: 15160331

Group type: EXPERIMENTAL
Intervention: Standard-dose adjuvant chemotherapy
Number of subjects: 18
Study: 10978398

Group type: EXPERIMENTAL
Intervention: High-flux biocompatible membrane
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional cellulose membrane
Number of subjects: 84

Group type: COMPARATOR
Intervention: Erythropoietin therapy in conventional group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy in experimental group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Dialysis dose (Kt/V) in conventional group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Dialysis dose (Kt/V) in experimental group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Beta(2)-microglobulin levels in experimental group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Beta(2)-microglobulin levels in conventional group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Erythropoietin doses in conventional group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Erythropoietin doses in experimental group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Erythropoietin plasma levels in conventional group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Erythropoietin plasma levels in experimental group
Number of subjects: 84
Study: 9565733

Group type: EXPERIMENTAL
Intervention: Augmenting agent with SSRI antidepressant
Number of subjects: 80

Group type: COMPARATOR
Intervention: SSRI antidepressant
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 8417716

Group type: EXPERIMENTAL
Intervention: Digoxin (digitalization)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No digoxin (not digitalized)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall (malignant disease)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall (benign disease)
Number of subjects: 80
Study: 3746171

Group type: EXPERIMENTAL
Intervention: Dropping one tar group
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Dropping two tar groups
Number of subjects: 3

Group type: COMPARATOR
Intervention: All groups of smokers
Number of subjects: 3
Study: 31483910

Group type: EXPERIMENTAL
Intervention: Resveratrol treatment (800 mg/d for 40 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29724305

Group type: EXPERIMENTAL
Intervention: Lidocaine continuous pumping group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 28464754

Group type: EXPERIMENTAL
Intervention: Posterior approach (PA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lateral approach (LA)
Number of subjects: 80
Study: 26290682

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin 10/20 mg
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 23396737

Group type: EXPERIMENTAL
Intervention: Probiotics treatment (Lepicol formula containing Lactobacillus plantarum, Lactobacillus deslbrueckii, Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum) for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care for 6 months
Number of subjects: 20
Study: 20512995

Group type: EXPERIMENTAL
Intervention: Glycerol phenylbutyrate (GPB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sodium phenylbutyrate (NaPBA)
Number of subjects: 48
Study: 18400716

Group type: EXPERIMENTAL
Intervention: Sprinkles (SP)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Nutritabs (NT)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Nutributter (NB)
Number of subjects: 413

Group type: COMPARATOR
Intervention: No Intervention (NI)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Combined intervention groups (SP, NT, NB)
Number of subjects: 413